How M.D. was paid
$1.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Incentive | Total |
|---|---|---|---|
| Michael Henderson, M.D.Chief Executive Officer | $700,000 | $591,500 | $1,291,500 |
| Carl Dambkowski, M.D.Chief Medical Officer | $540,000 | $315,900 | $855,900 |
| Jane Pritchett HendersonChief Financial Officer | $540,000 | $315,900 | $855,900 |
What changed and why
- 3%Base salary increases for our NEOs ranged from 3% to 6% in 2025.
- 130%Annual bonuses for our NEOs were paid out at 130% of target based on corporate goals.
- NEOs received no new stock option grants in 2025 due to the timing of long-term incentive grants.
- 95%The percentage of pay that is at risk for our CEO in 2025 is 95%.
- The Company extended its projected cash runway into the second half of 2028 in 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.